Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteoglycans synthesis refers to a multistep biological process in which specific enzymes assemble core proteins and glycosaminoglycan (GAG) chains to generate proteoglycans—heterogeneous macromolecules that are major structural and functional components of the animal extracellular matrix. Synthesized in the endoplasmic reticulum and Golgi apparatus, their production involves sequential action by glycosyltransferases and sulfotransferases. Proteoglycans play crucial roles in tissue structure, hydration, cell adhesion, mechanosignaling, and regulation of growth factor bioavailability. Dysregulated proteoglycan synthesis or degradation is implicated in cancer, cardiovascular disease, connective tissue disorders such as Ehlers–Danlos syndrome, and inherited lysosomal storage disorders (mucopolysaccharidoses).
Enzyme inhibition (e.g., targeting glycosyltransferases, sulfotransferases, or heparanase to modulate glycosaminoglycan assembly and proteoglycan degradation); Anticoagulation (e.g., heparin binds antithrombin through specific glycosaminoglycan arrangements)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteoglycans synthesis.